<?xml version="1.0" ?>
<GlossaryTerm id="CDR0000635778">
  <TermName>CHOPE regimen</TermName>
  <TermPronunciation>(… REH-jih-men)</TermPronunciation>
  <TermDefinition>
    <DefinitionText>An abbreviation for a chemotherapy combination that is used to treat non-Hodgkin lymphoma. It includes the drugs cyclophosphamide, doxorubicin hydrochloride (hydroxydaunorubicin), vincristine sulfate (Oncovin), prednisone, and etoposide phosphate. Also called CHOPE.</DefinitionText>
    <Dictionary>Cancer.gov</Dictionary>
    <Audience>Patient</Audience>
  </TermDefinition>
  <MediaLink ref="CDR0000722861" type="audio/mpeg" alt="Pronunciation of dictionary term &quot;CHOPE regimen&quot;" language="en" id="_3"/>
  <MediaLink ref="CDR0000722862" type="audio/mpeg" alt="Pronunciation of dictionary term &quot;régimen CHOPE&quot;" language="es" id="_4"/>
  <SpanishTermName>régimen CHOPE</SpanishTermName>
  <SpanishTermDefinition>
    <DefinitionText>Nombre de una quimioterapia combinada que se usa para el tratamiento del linfoma no Hodgkin. Incluye los medicamentos ciclofosfamida, clorhidrato de doxorrubicina (hidroxidaunorrubicina), sulfato de vincristina (Oncovin), prednisona y sulfato de etopósido. También se llama CHOPE.</DefinitionText>
    <Dictionary>Cancer.gov</Dictionary>
    <Audience>Patient</Audience>
  </SpanishTermDefinition>
  <DateFirstPublished>2009-02-20</DateFirstPublished>
  <DateLastModified>2010-05-05</DateLastModified>
</GlossaryTerm>
